Biolargo Inc (BLGO)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
0.2827 -0.0023 (-0.81%) 03/20/25 [OTC US]
N/A x N/A N/A x N/A
Post-market 0.2827 unch (unch) 15:54 ET
for Thu, Mar 20th, 2025
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
Assets | |||||
Current Assets | |||||
Cash & Cash Equivalents | 3,882 | 4,765 | 4,336 | 3,539 | 3,042 |
Receivables | 3,209 | 2,104 | 2,473 | 2,612 | 1,453 |
Inventories | 238 | 176 | 251 | 153 | 122 |
TOTAL | $7,394 | $7,110 | $7,176 | $6,362 | $4,691 |
Non-Current Assets | |||||
PPE Net | 1,807 | 1,811 | 1,489 | 662 | 599 |
Investments And Advances | 15 | 18 | 18 | 19 | 15 |
Other Non-Current Assets | 1,089 | 1,114 | 1,138 | 1,162 | 1,240 |
TOTAL | $2,911 | $2,943 | $2,645 | $1,843 | $1,854 |
Total Assets | $10,305 | $10,053 | $9,821 | $8,205 | $6,545 |
Liabilities | |||||
Current Liabilities | |||||
Short Term Debt | 66 | 66 | 66 | 66 | 66 |
Accounts payable and accrued liabilities | 2,794 | 2,441 | 2,512 | 1,885 | 1,219 |
Other current liabilities | 101 | 166 | 487 | 420 | 122 |
TOTAL | $3,200 | $3,012 | $3,404 | $2,710 | $1,740 |
Non-Current Liabilities | |||||
Deferred Revenues | N/A | N/A | N/A | N/A | 2 |
aiOther Non-Current Liabilities | 1,647 | 1,488 | 1,634 | 1,584 | 1,296 |
TOTAL | $1,124 | $1,149 | $1,269 | $1,293 | $988 |
Total Liabilities | $4,324 | $4,161 | $4,673 | $4,003 | $2,728 |
Shareholders' Equity | |||||
Shares Outstanding, K | 301,179 | 300,619 | 296,840 | 295,553 | 289,500 |
Common Shares | 202 | 200 | 198 | 196 | 193 |
Retained earnings | -148,486 | -147,949 | -147,508 | -147,098 | -146,369 |
Other shareholders' equity | -2,826 | -352 | -3,148 | -2,919 | -3,413 |
TOTAL | $5,981 | $5,892 | $5,148 | $4,202 | $3,817 |
Total Liabilities And Equity | $10,305 | $10,053 | $9,821 | $8,205 | $6,545 |